What is a major risk associated with prolonged benzodiazepine use in the ICU?

• A. Hypertension and tachyarrhythmia
• B. Increased renal excretion
• C. Delirium, prolonged ventilation, and delayed emergence
• D. Immediate renal injury

Answer: (C)

Prolonged benzodiazepine use for ICU sedation mainly risks extended brain depression, which can manifest as delirium and delayed awakening. Delirium is a frequent and serious complication of continuous benzodiazepine infusions in critically ill patients, and it is directly linked to longer time on mechanical ventilation and slower emergence when we try to wean or stop sedation. The drugs’ sedative effects can accumulate, especially in patients with organ dysfunction, leading to prolonged sedation even after dosing stops. This combination—delirium along with delayed emergence and longer ventilation—drives worse outcomes in the ICU.

Hypertension and tachyarrhythmia aren’t typical issues associated with benzodiazepines; their cardiovascular effects are usually minimal or even sedating rather than driving high blood pressure or rapid heart rates. Increased renal excretion isn’t the main concern either, though some metabolites can complicate use in specific organ impairments. Immediate renal injury is not a characteristic risk of these medications in this context.